Advanced Cardiac Intervention Offers a Minimally Invasive Alternative to Heart Pathologies

One of the goals of advanced cardiac intervention is to address the most challenging heart health problems in the least invasive way. According to him Dr. Rafael Ruiz SalmeronThis means that “it is more effective to intervene on any type of valve or cardiac structure, such as the appendage. “It is now possible to perform a complex procedure using catheters, making patients’ recovery much easier and reducing the risks associated with any intervention.”

A clinic specialist in interventional cardiology took part in the third episode of the podcast “Knowing is Health.” In the framework of events organized to disseminate the achievements of modern cardiac interventional therapy under the motto “Valentine’s accomplices”, Dr. Ruiz Salmeron emphasized that the technique closure of the cardiac appendage It is a safe and effective alternative for patients with atrial fibrillation wishing to stop taking anticoagulants. “Our goal is for the patient suffering from this common arrhythmia to know that there are alternative options for living on chronic anticoagulation therapy.”

Cardiac adnexal closure is a procedure considered minimally invasive that involves closing a small cavity inside the heart where blood clots commonly form, increasing the likelihood of stroke or heart failure. The intervention lasts from one to two hours, and the patient is discharged the next day after surgery.

Anticoagulants are becoming safer

Dr. Ruiz Salmeron took part in a forum dedicated to patients receiving anticoagulants, organized by the University Hospital of Navarra in collaboration with Dr. Ramon Lecamberryco-director Hematology serviceand Rafael Martinez, President of the Spanish Federation of Anticoagulant Associations. At the meeting, experts tried to answer more than 400 interested patients about the most appropriate circumstances to stop this drug.

The three main scenarios in which chronic management is considered are patients with atrial fibrillation, patients with mechanical heart valves, and patients with various types of pulmonary thromboembolism. According to Dr. Lecamberry, “Although most lead normal lives, there are risk factors for bleeding that may contraindicate treatment beyond the need for this medication.” On a positive note, he added that “direct anticoagulants have proven to be at least as effective as Sintrom and, above all, much safer.”